Correlation Between RAMM Pharma and Canntab Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RAMM Pharma and Canntab Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RAMM Pharma and Canntab Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RAMM Pharma Corp and Canntab Therapeutics Limited, you can compare the effects of market volatilities on RAMM Pharma and Canntab Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RAMM Pharma with a short position of Canntab Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of RAMM Pharma and Canntab Therapeutics.

Diversification Opportunities for RAMM Pharma and Canntab Therapeutics

1.0
  Correlation Coefficient

No risk reduction

The 3 months correlation between RAMM and Canntab is 1.0. Overlapping area represents the amount of risk that can be diversified away by holding RAMM Pharma Corp and Canntab Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canntab Therapeutics and RAMM Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RAMM Pharma Corp are associated (or correlated) with Canntab Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canntab Therapeutics has no effect on the direction of RAMM Pharma i.e., RAMM Pharma and Canntab Therapeutics go up and down completely randomly.

Pair Corralation between RAMM Pharma and Canntab Therapeutics

If you would invest  1.30  in Canntab Therapeutics Limited on September 14, 2024 and sell it today you would lose (1.29) from holding Canntab Therapeutics Limited or give up 99.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy27.13%
ValuesDaily Returns

RAMM Pharma Corp  vs.  Canntab Therapeutics Limited

 Performance 
       Timeline  
RAMM Pharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days RAMM Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable primary indicators, RAMM Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Canntab Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Canntab Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, Canntab Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

RAMM Pharma and Canntab Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RAMM Pharma and Canntab Therapeutics

The main advantage of trading using opposite RAMM Pharma and Canntab Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RAMM Pharma position performs unexpectedly, Canntab Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canntab Therapeutics will offset losses from the drop in Canntab Therapeutics' long position.
The idea behind RAMM Pharma Corp and Canntab Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance